Evidence map›Paper›PMID 32517777›Full record

ArticleMolecular neurodegeneration2020

Sex-dependent calcium hyperactivity due to lysosomal-related dysfunction in astrocytes from APOE4 versus APOE3 gene targeted replacement mice.

Raquel Larramona-Arcas, Candela González-Arias, Gertrudis Perea, Antonia Gutiérrez, Javier Vitorica, Tamara García-Barrera, José Luis Gómez-Ariza, Raquel Pascua-Maestro, María Dolores Ganfornina, Eleanna Kara and 5 more

Open access · goldAbstract read
In one paragraph

Article in Molecular neurodegeneration, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 39 papers.

0numbers the graph read from it
0cells of the map it votes in
39citing papers in PubMed
4.4field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

39 citing papers in PubMed, 52 citations in OpenAlex.

  1. Review
  2. Excitation-inhibition homeostasis in Alzheimer's disease: a selective multiscale review of mechanisms, sex differences, and therapeutic opportunities.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2026
    Review
  3. Review
  4. Review
  5. Article
  6. Astrovascular decoupling in awake 5×FAD mice is associated with reduced astrocytic calcium.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025
    Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Astroglial activation: Current concepts and future directions.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2024
    Review
  14. Review
  15. Review
  16. Article
  17. APOE4 expression confers a mild, persistent reduction in neurovascular function in the visual cortex and hippocampus of awake mice.Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism · 2023
    Article
  18. Optogenetics in Alzheimer's Disease: Focus on Astrocytes.Antioxidants (Basel, Switzerland) · 2023
    Review
  19. Research progress in the evaluation of glymphatic system function by the DTI-ALPS method.Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences · 2023
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 7 institutions in 3 countries.

Raquel Larramona-ArcasUnitat de Bioquímica de Medicina, Departament de Bioquímica i Biologia Molecular, and, Institut de Neurociències (INc), Facultat de Medicina, Universitat Autònoma de Barcelona, 08193 Cerdanyola del Vallès, Barcelona, Catalonia, Spain.
Candela González-AriasCajal Institute, Consejo Superior de Investigaciones Científicas (CSIC), 28002, Madrid, Spain.
Gertrudis PereaCajal Institute, Consejo Superior de Investigaciones Científicas (CSIC), 28002, Madrid, Spain.
Antonia GutiérrezDepartamento de Biología Celular, Genética y Fisiología, Facultad de Ciencias, Instituto de Investigación Biomedica de Málaga (IBIMA), Universidad de Málaga, 29071, Málaga, Spain.
Javier VitoricaCentro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBERNED), 28031 Madrid, Spain.
Tamara García-BarreraDepartamento de Química, Facultad de Ciencias Experimentales, Campus de El Carmen, Centro de Investigación en Recursos Naturales, Salud y Medio Ambiente (RENSMA), Universidad de Huelva, 21007, Huelva, Spain.
José Luis Gómez-ArizaDepartamento de Química, Facultad de Ciencias Experimentales, Campus de El Carmen, Centro de Investigación en Recursos Naturales, Salud y Medio Ambiente (RENSMA), Universidad de Huelva, 21007, Huelva, Spain.
Raquel Pascua-MaestroDepartamento de Bioquímica y Biología Molecular y Fisiología, Instituto de Biología y Genética Molecular, Universidad de Valladolid-CSIC, 43007 Valladolid, Spain.
María Dolores GanforninaDepartamento de Bioquímica y Biología Molecular y Fisiología, Instituto de Biología y Genética Molecular, Universidad de Valladolid-CSIC, 43007 Valladolid, Spain.
Eleanna KaraAlzheimer's Disease Research Laboratory, MassGeneral Institute for Neurodegenerative Disease, Massachusetts General Hospital, Harvard Medical School, Charlestown, MA, 02129, USA.
Eloise HudryAlzheimer's Disease Research Laboratory, MassGeneral Institute for Neurodegenerative Disease, Massachusetts General Hospital, Harvard Medical School, Charlestown, MA, 02129, USA.
Marta Martinez-VicenteCentro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBERNED), 28031 Madrid, Spain.
Miquel VilaUnitat de Bioquímica de Medicina, Departament de Bioquímica i Biologia Molecular, and, Institut de Neurociències (INc), Facultat de Medicina, Universitat Autònoma de Barcelona, 08193 Cerdanyola del Vallès, Barcelona, Catalonia, Spain.
Elena GaleaUnitat de Bioquímica de Medicina, Departament de Bioquímica i Biologia Molecular, and, Institut de Neurociències (INc), Facultat de Medicina, Universitat Autònoma de Barcelona, 08193 Cerdanyola del Vallès, Barcelona, Catalonia, Spain.
Roser MasgrauUnitat de Bioquímica de Medicina, Departament de Bioquímica i Biologia Molecular, and, Institut de Neurociències (INc), Facultat de Medicina, Universitat Autònoma de Barcelona, 08193 Cerdanyola del Vallès, Barcelona, Catalonia, Spain. roser.masgrau@uab.cat.ORCID 0000-0002-6722-5939
Biomedical Research Networking Center on Neurodegenerative Diseases · ESConsejo Superior de Investigaciones Científicas · ESHarvard University · USInstitució Catalana de Recerca i Estudis Avançats · ESUniversidad de Huelva · ESUniversidad de Valladolid · ESUniversitat Autònoma de Barcelona · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe apolipoprotein E (APOE) gene exists in three isoforms in humans: APOE2, APOE3 and APOE4. APOE4 causes structural and functional alterations in normal brains, and is the strongest genetic risk factor of the sporadic form of Alzheimer's disease (LOAD). Research on APOE4 has mainly focused on the neuronal damage caused by defective cholesterol transport and exacerbated amyloid-β and Tau pathology. The impact of APOE4 on non-neuronal cell functions has been overlooked. Astrocytes, the main producers of ApoE in the healthy brain, are building blocks of neural circuits, and Ca

methodsCa

resultsWe found potentiation of ATP-elicited Ca

conclusionsImmortalized APOE4 versus APOE3 astrocytes present: increased Ca

Indexed as

Alzheimer DiseaseAnimalsApolipoprotein E3Apolipoprotein E4AstrocytesCalciumCholesterolFemaleHippocampusLysosomesMaleMice, TransgenicNeuronsApolipoprotein E3Apolipoprotein E4CalciumCholesterolAPOE4AstrocytesCalcium signalingLipidomeLysosomePurinergic receptorsSex

Identifiers

PMID32517777
PMCPMC7285605
OpenAlexW3034140617

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.